MRNA Vaccine Prevented Melanoma From Returning, Drugmakers Say

MRNA Vaccine Prevented Melanoma From Returning, Drugmakers Say The novel vaccine was customized to patients' tumors in a large-scale clinical trial. On Wednesday, Moderna and Merck announced that the vaccine had cleared a Phase 3 trial, the first mRNA cancer drug to do so, The Washington Post reported. The results could be a landmark moment in cancer treatment. https://kffhealthnews.org/morning-breakout/public-health-081926/